APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Neurokinin Receptor Antagonists

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Neurokinin Receptor Antagonists Market Analysis and Forecast 2026-2032

Report ID 174016520229 December 2025199 pages

Choose your research edition.

Industry ResearchNeurokinin Receptor Antagonists Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Neurokinin Receptor Antagonists Industry Growth and Trends Forecast to 203299 pages · $3,450 USDMarket StructureGlobal Neurokinin Receptor Antagonists Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032184 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Neurokinin Receptor Antagonists Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Neurokinin Receptor Antagonists Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Neurokinin Receptor Antagonists market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Neurokinin Receptor Antagonists is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Neurokinin Receptor Antagonists is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Neurokinin Receptor Antagonists is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Neurokinin Receptor Antagonists is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Neurokinin Receptor Antagonists include Merck, Bayer, Zoetis, TerSera Therapeutics, Heron Therapeutics, Helsinn Healthcare and Astellas Pharma, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Neurokinin Receptor Antagonists, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Neurokinin Receptor Antagonists, also provides the sales of main regions and countries. Of the upcoming market potential for Neurokinin Receptor Antagonists, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Neurokinin Receptor Antagonists sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Neurokinin Receptor Antagonists market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Neurokinin Receptor Antagonists sales, projected growth trends, production technology, application and end-user industry.

Neurokinin Receptor Antagonists Segment by Company

Merck

Bayer

Zoetis

TerSera Therapeutics

Heron Therapeutics

Helsinn Healthcare

Astellas Pharma

Neurokinin Receptor Antagonists Segment by Type

NK-1 Receptor Antagonists

NK-3 Receptor Antagonists

Others

Neurokinin Receptor Antagonists Segment by Application

Vasomotor Symptoms

Nausea and Vomiting

Others

Neurokinin Receptor Antagonists Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Neurokinin Receptor Antagonists market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Neurokinin Receptor Antagonists and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Neurokinin Receptor Antagonists.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Neurokinin Receptor Antagonists in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Neurokinin Receptor Antagonists manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Neurokinin Receptor Antagonists sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Neurokinin Receptor Antagonists Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. NK-1 Receptor Antagonists Major Manufacturers Table 3. NK-3 Receptor Antagonists Major Manufacturers Table 4. Others Major Manufacturers Table 5. Global Neurokinin Receptor Antagonists Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Vasomotor Symptoms Major Manufacturers Table 7. Nausea and Vomiting Major Manufacturers Table 8. Others Major Manufacturers Table 9. Neurokinin Receptor Antagonists Industry Trends Table 10. Neurokinin Receptor Antagonists Industry Drivers Table 11. Neurokinin Receptor Antagonists Industry Opportunities and Challenges Table 12. Neurokinin Receptor Antagonists Industry Restraints Table 13. Global Neurokinin Receptor Antagonists Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Neurokinin Receptor Antagonists Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Neurokinin Receptor Antagonists Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Neurokinin Receptor Antagonists Revenue Market Share by Region (2021-2026) Table 17. Global Neurokinin Receptor Antagonists Revenue Market Share by Region (2027-2032) Table 18. Global Neurokinin Receptor Antagonists Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 19. Global Neurokinin Receptor Antagonists Sales by Region (2021-2026) & (K Units) Table 20. Global Neurokinin Receptor Antagonists Sales by Region (2027-2032) & (K Units) Table 21. Global Neurokinin Receptor Antagonists Sales Market Share by Region (2021-2026) Table 22. Global Neurokinin Receptor Antagonists Sales Market Share by Region (2027-2032) Table 23. Global Neurokinin Receptor Antagonists Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Neurokinin Receptor Antagonists Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Neurokinin Receptor Antagonists Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Neurokinin Receptor Antagonists Sales Market Share by Manufacturers (2021-2026) Table 27. Global Neurokinin Receptor Antagonists Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 28. Global Neurokinin Receptor Antagonists Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Neurokinin Receptor Antagonists Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Neurokinin Receptor Antagonists Manufacturers, Product Type & Application Table 31. Global Neurokinin Receptor Antagonists Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Neurokinin Receptor Antagonists by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Neurokinin Receptor Antagonists Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Neurokinin Receptor Antagonists Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Neurokinin Receptor Antagonists Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Neurokinin Receptor Antagonists Revenue Market Share by Type (2021-2026) Table 38. Global Neurokinin Receptor Antagonists Revenue Market Share by Type (2027-2032) Table 39. Global Neurokinin Receptor Antagonists Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 40. Global Neurokinin Receptor Antagonists Sales by Type (2021-2026) & (K Units) Table 41. Global Neurokinin Receptor Antagonists Sales by Type (2027-2032) & (K Units) Table 42. Global Neurokinin Receptor Antagonists Sales Market Share by Type (2021-2026) Table 43. Global Neurokinin Receptor Antagonists Sales Market Share by Type (2027-2032) Table 44. Global Neurokinin Receptor Antagonists Price by Type (2021-2026) & (US$/Unit) Table 45. Global Neurokinin Receptor Antagonists Price by Type (2027-2032) & (US$/Unit) Table 46. Global Neurokinin Receptor Antagonists Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Neurokinin Receptor Antagonists Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Neurokinin Receptor Antagonists Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Neurokinin Receptor Antagonists Revenue Market Share by Application (2021-2026) Table 50. Global Neurokinin Receptor Antagonists Revenue Market Share by Application (2027-2032) Table 51. Global Neurokinin Receptor Antagonists Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 52. Global Neurokinin Receptor Antagonists Sales by Application (2021-2026) & (K Units) Table 53. Global Neurokinin Receptor Antagonists Sales by Application (2027-2032) & (K Units) Table 54. Global Neurokinin Receptor Antagonists Sales Market Share by Application (2021-2026) Table 55. Global Neurokinin Receptor Antagonists Sales Market Share by Application (2027-2032) Table 56. Global Neurokinin Receptor Antagonists Price by Application (2021-2026) & (US$/Unit) Table 57. Global Neurokinin Receptor Antagonists Price by Application (2027-2032) & (US$/Unit) Table 58. Merck Company Information Table 59. Merck Business Overview Table 60. Merck Neurokinin Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Merck Neurokinin Receptor Antagonists Product Portfolio Table 62. Merck Recent Development Table 63. Bayer Company Information Table 64. Bayer Business Overview Table 65. Bayer Neurokinin Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Bayer Neurokinin Receptor Antagonists Product Portfolio Table 67. Bayer Recent Development Table 68. Zoetis Company Information Table 69. Zoetis Business Overview Table 70. Zoetis Neurokinin Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Zoetis Neurokinin Receptor Antagonists Product Portfolio Table 72. Zoetis Recent Development Table 73. TerSera Therapeutics Company Information Table 74. TerSera Therapeutics Business Overview Table 75. TerSera Therapeutics Neurokinin Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. TerSera Therapeutics Neurokinin Receptor Antagonists Product Portfolio Table 77. TerSera Therapeutics Recent Development Table 78. Heron Therapeutics Company Information Table 79. Heron Therapeutics Business Overview Table 80. Heron Therapeutics Neurokinin Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Heron Therapeutics Neurokinin Receptor Antagonists Product Portfolio Table 82. Heron Therapeutics Recent Development Table 83. Helsinn Healthcare Company Information Table 84. Helsinn Healthcare Business Overview Table 85. Helsinn Healthcare Neurokinin Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Helsinn Healthcare Neurokinin Receptor Antagonists Product Portfolio Table 87. Helsinn Healthcare Recent Development Table 88. Astellas Pharma Company Information Table 89. Astellas Pharma Business Overview Table 90. Astellas Pharma Neurokinin Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Astellas Pharma Neurokinin Receptor Antagonists Product Portfolio Table 92. Astellas Pharma Recent Development Table 93. North America Neurokinin Receptor Antagonists Revenue by Type (2021-2026) & (US$ Million) Table 94. North America Neurokinin Receptor Antagonists Revenue by Type (2027-2032) & (US$ Million) Table 95. North America Neurokinin Receptor Antagonists Sales by Type (2021-2026) & (K Units) Table 96. North America Neurokinin Receptor Antagonists Sales by Type (2027-2032) & (K Units) Table 97. North America Neurokinin Receptor Antagonists Sales Price by Type (2021-2026) & (US$/Unit) Table 98. North America Neurokinin Receptor Antagonists Sales Price by Type (2027-2032) & (US$/Unit) Table 99. North America Neurokinin Receptor Antagonists Revenue by Application (2021-2026) & (US$ Million) Table 100. North America Neurokinin Receptor Antagonists Revenue by Application (2027-2032) & (US$ Million) Table 101. North America Neurokinin Receptor Antagonists Sales by Application (2021-2026) & (K Units) Table 102. North America Neurokinin Receptor Antagonists Sales by Application (2027-2032) & (K Units) Table 103. North America Neurokinin Receptor Antagonists Sales Price by Application (2021-2026) & (US$/Unit) Table 104. North America Neurokinin Receptor Antagonists Sales Price by Application (2027-2032) & (US$/Unit) Table 105. North America Neurokinin Receptor Antagonists Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 106. North America Neurokinin Receptor Antagonists Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 107. North America Neurokinin Receptor Antagonists Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 108. North America Neurokinin Receptor Antagonists Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 109. North America Neurokinin Receptor Antagonists Sales by Country (2021-2026) & (K Units) Table 110. North America Neurokinin Receptor Antagonists Sales by Country (2027-2032) & (K Units) Table 111. North America Neurokinin Receptor Antagonists Sales Price by Country (2021-2026) & (US$/Unit) Table 112. North America Neurokinin Receptor Antagonists Sales Price by Country (2027-2032) & (US$/Unit) Table 113. United States Neurokinin Receptor Antagonists Revenue (2021-2032) & (US$ Million) Table 114. Canada Neurokinin Receptor Antagonists Revenue (2021-2032) & (US$ Million) Table 115. Mexico Neurokinin Receptor Antagonists Revenue (2021-2032) & (US$ Million) Table 116. Europe Neurokinin Receptor Antagonists Revenue by Type (2021-2026) & (US$ Million) Table 117. Europe Neurokinin Receptor Antagonists Revenue by Type (2027-2032) & (US$ Million) Table 118. Europe Neurokinin Receptor Antagonists Sales by Type (2021-2026) & (K Units) Table 119. Europe Neurokinin Receptor Antagonists Sales by Type (2027-2032) & (K Units) Table 120. Europe Neurokinin Receptor Antagonists Sales Price by Type (2021-2026) & (US$/Unit) Table 121. Europe Neurokinin Receptor Antagonists Sales Price by Type (2027-2032) & (US$/Unit) Table 122. Europe Neurokinin Receptor Antagonists Revenue by Application (2021-2026) & (US$ Million) Table 123. Europe Neurokinin Receptor Antagonists Revenue by Application (2027-2032) & (US$ Million) Table 124. Europe Neurokinin Receptor Antagonists Sales by Application (2021-2026) & (K Units) Table 125. Europe Neurokinin Receptor Antagonists Sales by Application (2027-2032) & (K Units) Table 126. Europe Neurokinin Receptor Antagonists Sales Price by Application (2021-2026) & (US$/Unit) Table 127. Europe Neurokinin Receptor Antagonists Sales Price by Application (2027-2032) & (US$/Unit) Table 128. Europe Neurokinin Receptor Antagonists Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 129. Europe Neurokinin Receptor Antagonists Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 130. Europe Neurokinin Receptor Antagonists Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 131. Europe Neurokinin Receptor Antagonists Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 132. Europe Neurokinin Receptor Antagonists Sales by Country (2021-2026) & (K Units) Table 133. Europe Neurokinin Receptor Antagonists Sales by Country (2027-2032) & (K Units) Table 134. Europe Neurokinin Receptor Antagonists Sales Price by Country (2021-2026) & (US$/Unit) Table 135. Europe Neurokinin Receptor Antagonists Sales Price by Country (2027-2032) & (US$/Unit) Table 136. Germany Neurokinin Receptor Antagonists Revenue (2021-2032) & (US$ Million) Table 137. France Neurokinin Receptor Antagonists Revenue (2021-2032) & (US$ Million) Table 138. U.K. Neurokinin Receptor Antagonists Revenue (2021-2032) & (US$ Million) Table 139. Italy Neurokinin Receptor Antagonists Revenue (2021-2032) & (US$ Million) Table 140. Russia Neurokinin Receptor Antagonists Revenue (2021-2032) & (US$ Million) Table 141. Spain Neurokinin Receptor Antagonists Revenue (2021-2032) & (US$ Million) Table 142. Netherlands Neurokinin Receptor Antagonists Revenue (2021-2032) & (US$ Million) Table 143. Switzerland Neurokinin Receptor Antagonists Revenue (2021-2032) & (US$ Million) Table 144. Sweden Neurokinin Receptor Antagonists Revenue (2021-2032) & (US$ Million) Table 145. Poland Neurokinin Receptor Antagonists Revenue (2021-2032) & (US$ Million) Table 146. China Neurokinin Receptor Antagonists Revenue by Type (2021-2026) & (US$ Million) Table 147. China Neurokinin Receptor Antagonists Revenue by Type (2027-2032) & (US$ Million) Table 148. China Neurokinin Receptor Antagonists Sales by Type (2021-2026) & (K Units) Table 149. China Neurokinin Receptor Antagonists Sales by Type (2027-2032) & (K Units) Table 150. China Neurokinin Receptor Antagonists Sales Price by Type (2021-2026) & (US$/Unit) Table 151. China Neurokinin Receptor Antagonists Sales Price by Type (2027-2032) & (US$/Unit) Table 152. China Neurokinin Receptor Antagonists Revenue by Application (2021-2026) & (US$ Million) Table 153. China Neurokinin Receptor Antagonists Revenue by Application (2027-2032) & (US$ Million) Table 154. China Neurokinin Receptor Antagonists Sales by Application (2021-2026) & (K Units) Table 155. China Neurokinin Receptor Antagonists Sales by Application (2027-2032) & (K Units) Table 156. China Neurokinin Receptor Antagonists Sales Price by Application (2021-2026) & (US$/Unit) Table 157. China Neurokinin Receptor Antagonists Sales Price by Application (2027-2032) & (US$/Unit) Table 158. Asia Neurokinin Receptor Antagonists Revenue by Type (2021-2026) & (US$ Million) Table 159. Asia Neurokinin Receptor Antagonists Revenue by Type (2027-2032) & (US$ Million) Table 160. Asia Neurokinin Receptor Antagonists Sales by Type (2021-2026) & (K Units) Table 161. Asia Neurokinin Receptor Antagonists Sales by Type (2027-2032) & (K Units) Table 162. Asia Neurokinin Receptor Antagonists Sales Price by Type (2021-2026) & (US$/Unit) Table 163. Asia Neurokinin Receptor Antagonists Sales Price by Type (2027-2032) & (US$/Unit) Table 164. Asia Neurokinin Receptor Antagonists Revenue by Application (2021-2026) & (US$ Million) Table 165. Asia Neurokinin Receptor Antagonists Revenue by Application (2027-2032) & (US$ Million) Table 166. Asia Neurokinin Receptor Antagonists Sales by Application (2021-2026) & (K Units) Table 167. Asia Neurokinin Receptor Antagonists Sales by Application (2027-2032) & (K Units) Table 168. Asia Neurokinin Receptor Antagonists Sales Price by Application (2021-2026) & (US$/Unit) Table 169. Asia Neurokinin Receptor Antagonists Sales Price by Application (2027-2032) & (US$/Unit) Table 170. Asia Neurokinin Receptor Antagonists Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 171. Asia Neurokinin Receptor Antagonists Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 172. Asia Neurokinin Receptor Antagonists Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 173. Asia Neurokinin Receptor Antagonists Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 174. Asia Neurokinin Receptor Antagonists Sales by Country (2021-2026) & (K Units) Table 175. Asia Neurokinin Receptor Antagonists Sales by Country (2027-2032) & (K Units) Table 176. Asia Neurokinin Receptor Antagonists Sales Price by Country (2021-2026) & (US$/Unit) Table 177. Asia Neurokinin Receptor Antagonists Sales Price by Country (2027-2032) & (US$/Unit) Table 178. Japan Neurokinin Receptor Antagonists Revenue (2021-2032) & (US$ Million) Table 179. South Korea Neurokinin Receptor Antagonists Revenue (2021-2032) & (US$ Million) Table 180. India Neurokinin Receptor Antagonists Revenue (2021-2032) & (US$ Million) Table 181. Australia Neurokinin Receptor Antagonists Revenue (2021-2032) & (US$ Million) Table 182. Taiwan Neurokinin Receptor Antagonists Revenue (2021-2032) & (US$ Million) Table 183. Southeast Asia Neurokinin Receptor Antagonists Revenue (2021-2032) & (US$ Million) Table 184. SAMEA Neurokinin Receptor Antagonists Revenue by Type (2021-2026) & (US$ Million) Table 185. SAMEA Neurokinin Receptor Antagonists Revenue by Type (2027-2032) & (US$ Million) Table 186. SAMEA Neurokinin Receptor Antagonists Sales by Type (2021-2026) & (K Units) Table 187. SAMEA Neurokinin Receptor Antagonists Sales by Type (2027-2032) & (K Units) Table 188. SAMEA Neurokinin Receptor Antagonists Sales Price by Type (2021-2026) & (US$/Unit) Table 189. SAMEA Neurokinin Receptor Antagonists Sales Price by Type (2027-2032) & (US$/Unit) Table 190. SAMEA Neurokinin Receptor Antagonists Revenue by Application (2021-2026) & (US$ Million) Table 191. SAMEA Neurokinin Receptor Antagonists Revenue by Application (2027-2032) & (US$ Million) Table 192. SAMEA Neurokinin Receptor Antagonists Sales by Application (2021-2026) & (K Units) Table 193. SAMEA Neurokinin Receptor Antagonists Sales by Application (2027-2032) & (K Units) Table 194. SAMEA Neurokinin Receptor Antagonists Sales Price by Application (2021-2026) & (US$/Unit) Table 195. SAMEA Neurokinin Receptor Antagonists Sales Price by Application (2027-2032) & (US$/Unit) Table 196. SAMEA Neurokinin Receptor Antagonists Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 197. SAMEA Neurokinin Receptor Antagonists Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 198. SAMEA Neurokinin Receptor Antagonists Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 199. SAMEA Neurokinin Receptor Antagonists Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 200. SAMEA Neurokinin Receptor Antagonists Sales by Country (2021-2026) & (K Units) Table 201. SAMEA Neurokinin Receptor Antagonists Sales by Country (2027-2032) & (K Units) Table 202. SAMEA Neurokinin Receptor Antagonists Sales Price by Country (2021-2026) & (US$/Unit) Table 203. SAMEA Neurokinin Receptor Antagonists Sales Price by Country (2027-2032) & (US$/Unit) Table 204. Brazil Neurokinin Receptor Antagonists Revenue (2021-2032) & (US$ Million) Table 205. Argentina Neurokinin Receptor Antagonists Revenue (2021-2032) & (US$ Million) Table 206. Chile Neurokinin Receptor Antagonists Revenue (2021-2032) & (US$ Million) Table 207. Colombia Neurokinin Receptor Antagonists Revenue (2021-2032) & (US$ Million) Table 208. Peru Neurokinin Receptor Antagonists Revenue (2021-2032) & (US$ Million) Table 209. Saudi Arabia Neurokinin Receptor Antagonists Revenue (2021-2032) & (US$ Million) Table 210. Israel Neurokinin Receptor Antagonists Revenue (2021-2032) & (US$ Million) Table 211. UAE Neurokinin Receptor Antagonists Revenue (2021-2032) & (US$ Million) Table 212. Turkey Neurokinin Receptor Antagonists Revenue (2021-2032) & (US$ Million) Table 213. Iran Neurokinin Receptor Antagonists Revenue (2021-2032) & (US$ Million) Table 214. Egypt Neurokinin Receptor Antagonists Revenue (2021-2032) & (US$ Million) Table 215. Key Raw Materials Table 216. Raw Materials Key Suppliers Table 217. Neurokinin Receptor Antagonists Distributors List Table 218. Neurokinin Receptor Antagonists Customers List Table 219. Research Programs/Design for This Report Table 220. Authors List of This Report Table 221. Secondary Sources Table 222. Primary Sources List of Figures Figure 1. Neurokinin Receptor Antagonists Image Figure 2. Global Neurokinin Receptor Antagonists Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Neurokinin Receptor Antagonists Market Size Share 2021 VS 2025 VS 2032 Figure 4. NK-1 Receptor Antagonists Image Figure 5. NK-3 Receptor Antagonists Image Figure 6. Others Image Figure 7. Global Neurokinin Receptor Antagonists Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Neurokinin Receptor Antagonists Market Size Share 2021 VS 2025 VS 2032 Figure 9. Vasomotor Symptoms Image Figure 10. Nausea and Vomiting Image Figure 11. Others Image Figure 12. Global Neurokinin Receptor Antagonists Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Neurokinin Receptor Antagonists Revenue (2021-2032) & (US$ Million) Figure 14. Global Neurokinin Receptor Antagonists Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Neurokinin Receptor Antagonists Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Neurokinin Receptor Antagonists Revenue Market Share by Region (2021-2032) Figure 17. Global Neurokinin Receptor Antagonists Sales (2021-2032) & (K Units) Figure 18. Global Neurokinin Receptor Antagonists Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 19. Global Neurokinin Receptor Antagonists Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico Neurokinin Receptor Antagonists Sales YoY (2021-2032) & (K Units) Figure 21. Europe Neurokinin Receptor Antagonists Sales YoY (2021-2032) & (K Units) Figure 22. China Neurokinin Receptor Antagonists Sales YoY (2021-2032) & (K Units) Figure 23. Asia (Excluding China) Neurokinin Receptor Antagonists Sales YoY (2021-2032) & (K Units) Figure 24. South America, Middle East and Africa Neurokinin Receptor Antagonists Sales YoY (2021-2032) & (K Units) Figure 25. Global Neurokinin Receptor Antagonists Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global Neurokinin Receptor Antagonists Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global Neurokinin Receptor Antagonists Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Neurokinin Receptor Antagonists Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global Neurokinin Receptor Antagonists Revenue Market Share by Type (2021-2032) Figure 31. Global Neurokinin Receptor Antagonists Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 32. Global Neurokinin Receptor Antagonists Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Neurokinin Receptor Antagonists Sales Market Share by Type (2021-2032) Figure 34. Global Neurokinin Receptor Antagonists Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Neurokinin Receptor Antagonists Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global Neurokinin Receptor Antagonists Revenue Market Share by Application (2021-2032) Figure 37. Global Neurokinin Receptor Antagonists Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 38. Global Neurokinin Receptor Antagonists Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Neurokinin Receptor Antagonists Sales Market Share by Application (2021-2032) Figure 40. North America Neurokinin Receptor Antagonists Revenue Share by Type (2021-2032) Figure 41. North America Neurokinin Receptor Antagonists Sales Share by Type (2021-2032) Figure 42. North America Neurokinin Receptor Antagonists Revenue Share by Application (2021-2032) Figure 43. North America Neurokinin Receptor Antagonists Sales Share by Application (2021-2032) Figure 44. North America Neurokinin Receptor Antagonists Revenue Share by Country (2021-2032) Figure 45. North America Neurokinin Receptor Antagonists Sales Share by Country (2021-2032) Figure 46. Europe Neurokinin Receptor Antagonists Revenue Share by Type (2021-2032) Figure 47. Europe Neurokinin Receptor Antagonists Sales Share by Type (2021-2032) Figure 48. Europe Neurokinin Receptor Antagonists Revenue Share by Application (2021-2032) Figure 49. Europe Neurokinin Receptor Antagonists Sales Share by Application (2021-2032) Figure 50. Europe Neurokinin Receptor Antagonists Revenue Share by Country (2021-2032) Figure 51. Europe Neurokinin Receptor Antagonists Sales Share by Country (2021-2032) Figure 52. China Neurokinin Receptor Antagonists Revenue Share by Type (2021-2032) Figure 53. China Neurokinin Receptor Antagonists Sales Share by Type (2021-2032) Figure 54. China Neurokinin Receptor Antagonists Revenue Share by Application (2021-2032) Figure 55. China Neurokinin Receptor Antagonists Sales Share by Application (2021-2032) Figure 56. Asia Neurokinin Receptor Antagonists Revenue Share by Type (2021-2032) Figure 57. Asia Neurokinin Receptor Antagonists Sales Share by Type (2021-2032) Figure 58. Asia Neurokinin Receptor Antagonists Revenue Share by Application (2021-2032) Figure 59. Asia Neurokinin Receptor Antagonists Sales Share by Application (2021-2032) Figure 60. Asia Neurokinin Receptor Antagonists Revenue Share by Country (2021-2032) Figure 61. Asia Neurokinin Receptor Antagonists Sales Share by Country (2021-2032) Figure 62. SAMEA Neurokinin Receptor Antagonists Revenue Share by Type (2021-2032) Figure 63. SAMEA Neurokinin Receptor Antagonists Sales Share by Type (2021-2032) Figure 64. SAMEA Neurokinin Receptor Antagonists Revenue Share by Application (2021-2032) Figure 65. SAMEA Neurokinin Receptor Antagonists Sales Share by Application (2021-2032) Figure 66. SAMEA Neurokinin Receptor Antagonists Revenue Share by Country (2021-2032) Figure 67. SAMEA Neurokinin Receptor Antagonists Sales Share by Country (2021-2032) Figure 68. Neurokinin Receptor Antagonists Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Neurokinin Receptor Antagonists Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • NK-1 Receptor Antagonists
  • NK-3 Receptor Antagonists
  • Others
Applications
  • Vasomotor Symptoms
  • Nausea and Vomiting
  • Others
Companies covered
  • Merck
  • Bayer
  • Zoetis
  • TerSera Therapeutics
  • Heron Therapeutics
  • Helsinn Healthcare
  • Astellas Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Neurokinin Receptor Antagonists Market by Type
  3. 1.2.1 Global Neurokinin Receptor Antagonists Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 NK-1 Receptor Antagonists
  5. 1.2.3 NK-3 Receptor Antagonists
  6. 1.2.4 Others
  7. 1.3 Neurokinin Receptor Antagonists Market by Application
  8. 1.3.1 Global Neurokinin Receptor Antagonists Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Vasomotor Symptoms
  10. 1.3.3 Nausea and Vomiting
  11. 1.3.4 Others
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Neurokinin Receptor Antagonists Market Dynamics
  1. 2.1 Neurokinin Receptor Antagonists Industry Trends
  2. 2.2 Neurokinin Receptor Antagonists Industry Drivers
  3. 2.3 Neurokinin Receptor Antagonists Industry Opportunities and Challenges
  4. 2.4 Neurokinin Receptor Antagonists Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Neurokinin Receptor Antagonists Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Neurokinin Receptor Antagonists Revenue by Region
  3. 3.2.1 Global Neurokinin Receptor Antagonists Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Neurokinin Receptor Antagonists Revenue by Region (2021-2026)
  5. 3.2.3 Global Neurokinin Receptor Antagonists Revenue by Region (2027-2032)
  6. 3.2.4 Global Neurokinin Receptor Antagonists Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Neurokinin Receptor Antagonists Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Neurokinin Receptor Antagonists Sales by Region
  9. 3.4.1 Global Neurokinin Receptor Antagonists Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Neurokinin Receptor Antagonists Sales by Region (2021-2026)
  11. 3.4.3 Global Neurokinin Receptor Antagonists Sales by Region (2027-2032)
  12. 3.4.4 Global Neurokinin Receptor Antagonists Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Neurokinin Receptor Antagonists Revenue by Manufacturers
  2. 4.1.1 Global Neurokinin Receptor Antagonists Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Neurokinin Receptor Antagonists Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Neurokinin Receptor Antagonists Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Neurokinin Receptor Antagonists Sales by Manufacturers
  6. 4.2.1 Global Neurokinin Receptor Antagonists Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Neurokinin Receptor Antagonists Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Neurokinin Receptor Antagonists Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Neurokinin Receptor Antagonists Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Neurokinin Receptor Antagonists Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Neurokinin Receptor Antagonists Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Neurokinin Receptor Antagonists Manufacturers, Product Type & Application
  13. 4.7 Global Neurokinin Receptor Antagonists Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Neurokinin Receptor Antagonists Market CR5 and HHI
  16. 4.8.2 2025 Neurokinin Receptor Antagonists Tier 1, Tier 2, and Tier 3
5 Neurokinin Receptor Antagonists Market by Type
  1. 5.1 Global Neurokinin Receptor Antagonists Revenue by Type
  2. 5.1.1 Global Neurokinin Receptor Antagonists Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Neurokinin Receptor Antagonists Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Neurokinin Receptor Antagonists Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Neurokinin Receptor Antagonists Sales by Type
  6. 5.2.1 Global Neurokinin Receptor Antagonists Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Neurokinin Receptor Antagonists Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Neurokinin Receptor Antagonists Sales Market Share by Type (2021-2032)
  9. 5.3 Global Neurokinin Receptor Antagonists Price by Type
6 Neurokinin Receptor Antagonists Market by Application
  1. 6.1 Global Neurokinin Receptor Antagonists Revenue by Application
  2. 6.1.1 Global Neurokinin Receptor Antagonists Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Neurokinin Receptor Antagonists Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Neurokinin Receptor Antagonists Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Neurokinin Receptor Antagonists Sales by Application
  6. 6.2.1 Global Neurokinin Receptor Antagonists Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Neurokinin Receptor Antagonists Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Neurokinin Receptor Antagonists Sales Market Share by Application (2021-2032)
  9. 6.3 Global Neurokinin Receptor Antagonists Price by Application
7 Company Profiles
  1. 7.1 Merck
  2. 7.1.1 Merck Company Information
  3. 7.1.2 Merck Business Overview
  4. 7.1.3 Merck Neurokinin Receptor Antagonists Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Merck Neurokinin Receptor Antagonists Product Portfolio
  6. 7.1.5 Merck Recent Developments
  7. 7.2 Bayer
  8. 7.2.1 Bayer Company Information
  9. 7.2.2 Bayer Business Overview
  10. 7.2.3 Bayer Neurokinin Receptor Antagonists Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Bayer Neurokinin Receptor Antagonists Product Portfolio
  12. 7.2.5 Bayer Recent Developments
  13. 7.3 Zoetis
  14. 7.3.1 Zoetis Company Information
  15. 7.3.2 Zoetis Business Overview
  16. 7.3.3 Zoetis Neurokinin Receptor Antagonists Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Zoetis Neurokinin Receptor Antagonists Product Portfolio
  18. 7.3.5 Zoetis Recent Developments
  19. 7.4 TerSera Therapeutics
  20. 7.4.1 TerSera Therapeutics Company Information
  21. 7.4.2 TerSera Therapeutics Business Overview
  22. 7.4.3 TerSera Therapeutics Neurokinin Receptor Antagonists Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 TerSera Therapeutics Neurokinin Receptor Antagonists Product Portfolio
  24. 7.4.5 TerSera Therapeutics Recent Developments
  25. 7.5 Heron Therapeutics
  26. 7.5.1 Heron Therapeutics Company Information
  27. 7.5.2 Heron Therapeutics Business Overview
  28. 7.5.3 Heron Therapeutics Neurokinin Receptor Antagonists Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Heron Therapeutics Neurokinin Receptor Antagonists Product Portfolio
  30. 7.5.5 Heron Therapeutics Recent Developments
  31. 7.6 Helsinn Healthcare
  32. 7.6.1 Helsinn Healthcare Company Information
  33. 7.6.2 Helsinn Healthcare Business Overview
  34. 7.6.3 Helsinn Healthcare Neurokinin Receptor Antagonists Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Helsinn Healthcare Neurokinin Receptor Antagonists Product Portfolio
  36. 7.6.5 Helsinn Healthcare Recent Developments
  37. 7.7 Astellas Pharma
  38. 7.7.1 Astellas Pharma Company Information
  39. 7.7.2 Astellas Pharma Business Overview
  40. 7.7.3 Astellas Pharma Neurokinin Receptor Antagonists Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Astellas Pharma Neurokinin Receptor Antagonists Product Portfolio
  42. 7.7.5 Astellas Pharma Recent Developments
8 North America
  1. 8.1 North America Neurokinin Receptor Antagonists Market Size by Type
  2. 8.1.1 North America Neurokinin Receptor Antagonists Revenue by Type (2021-2032)
  3. 8.1.2 North America Neurokinin Receptor Antagonists Sales by Type (2021-2032)
  4. 8.1.3 North America Neurokinin Receptor Antagonists Price by Type (2021-2032)
  5. 8.2 North America Neurokinin Receptor Antagonists Market Size by Application
  6. 8.2.1 North America Neurokinin Receptor Antagonists Revenue by Application (2021-2032)
  7. 8.2.2 North America Neurokinin Receptor Antagonists Sales by Application (2021-2032)
  8. 8.2.3 North America Neurokinin Receptor Antagonists Price by Application (2021-2032)
  9. 8.3 North America Neurokinin Receptor Antagonists Market Size by Country
  10. 8.3.1 North America Neurokinin Receptor Antagonists Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Neurokinin Receptor Antagonists Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Neurokinin Receptor Antagonists Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Neurokinin Receptor Antagonists Market Size by Type
  2. 9.1.1 Europe Neurokinin Receptor Antagonists Revenue by Type (2021-2032)
  3. 9.1.2 Europe Neurokinin Receptor Antagonists Sales by Type (2021-2032)
  4. 9.1.3 Europe Neurokinin Receptor Antagonists Price by Type (2021-2032)
  5. 9.2 Europe Neurokinin Receptor Antagonists Market Size by Application
  6. 9.2.1 Europe Neurokinin Receptor Antagonists Revenue by Application (2021-2032)
  7. 9.2.2 Europe Neurokinin Receptor Antagonists Sales by Application (2021-2032)
  8. 9.2.3 Europe Neurokinin Receptor Antagonists Price by Application (2021-2032)
  9. 9.3 Europe Neurokinin Receptor Antagonists Market Size by Country
  10. 9.3.1 Europe Neurokinin Receptor Antagonists Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Neurokinin Receptor Antagonists Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Neurokinin Receptor Antagonists Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Neurokinin Receptor Antagonists Market Size by Type
  2. 10.1.1 China Neurokinin Receptor Antagonists Revenue by Type (2021-2032)
  3. 10.1.2 China Neurokinin Receptor Antagonists Sales by Type (2021-2032)
  4. 10.1.3 China Neurokinin Receptor Antagonists Price by Type (2021-2032)
  5. 10.2 China Neurokinin Receptor Antagonists Market Size by Application
  6. 10.2.1 China Neurokinin Receptor Antagonists Revenue by Application (2021-2032)
  7. 10.2.2 China Neurokinin Receptor Antagonists Sales by Application (2021-2032)
  8. 10.2.3 China Neurokinin Receptor Antagonists Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Neurokinin Receptor Antagonists Market Size by Type
  2. 11.1.1 Asia Neurokinin Receptor Antagonists Revenue by Type (2021-2032)
  3. 11.1.2 Asia Neurokinin Receptor Antagonists Sales by Type (2021-2032)
  4. 11.1.3 Asia Neurokinin Receptor Antagonists Price by Type (2021-2032)
  5. 11.2 Asia Neurokinin Receptor Antagonists Market Size by Application
  6. 11.2.1 Asia Neurokinin Receptor Antagonists Revenue by Application (2021-2032)
  7. 11.2.2 Asia Neurokinin Receptor Antagonists Sales by Application (2021-2032)
  8. 11.2.3 Asia Neurokinin Receptor Antagonists Price by Application (2021-2032)
  9. 11.3 Asia Neurokinin Receptor Antagonists Market Size by Country
  10. 11.3.1 Asia Neurokinin Receptor Antagonists Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Neurokinin Receptor Antagonists Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Neurokinin Receptor Antagonists Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Neurokinin Receptor Antagonists Market Size by Type
  2. 12.1.1 SAMEA Neurokinin Receptor Antagonists Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Neurokinin Receptor Antagonists Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Neurokinin Receptor Antagonists Price by Type (2021-2032)
  5. 12.2 SAMEA Neurokinin Receptor Antagonists Market Size by Application
  6. 12.2.1 SAMEA Neurokinin Receptor Antagonists Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Neurokinin Receptor Antagonists Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Neurokinin Receptor Antagonists Price by Application (2021-2032)
  9. 12.3 SAMEA Neurokinin Receptor Antagonists Market Size by Country
  10. 12.3.1 SAMEA Neurokinin Receptor Antagonists Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Neurokinin Receptor Antagonists Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Neurokinin Receptor Antagonists Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Neurokinin Receptor Antagonists Value Chain Analysis
  2. 13.1.1 Neurokinin Receptor Antagonists Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Neurokinin Receptor Antagonists Production Mode & Process
  6. 13.2 Neurokinin Receptor Antagonists Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Neurokinin Receptor Antagonists Distributors
  9. 13.2.3 Neurokinin Receptor Antagonists Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst